Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

KYTHERA Biopharmaceuticals Inc (NASDAQ:KYTH)

Friday’s trading has closed, but KYTH is being traded in the after-hours session. After-Hours quote »
74.71
Delayed Data
As of 3:59pm ET
 -0.01 / -0.01%
Today’s Change
29.86
Today|||52-Week Range
76.31
+115.43%
Year-to-Date

Today’s Trading

Previous close74.72
Today’s open74.69
Day’s range74.69 - 74.78
Volume487,061
Average volume (3 months)943,470
Market cap$2.0B
Dividend yield--
Data as of 3:59pm ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)-122.88%
Earnings growth (this year)-25.95%
Earnings growth (next 5 years)+21.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book28.53

Competitors

 Today’s
change
Today’s
% change
CCMPCabot Microelectroni...-0.77-1.79%
OCIPOCI Partners LP-0.04-0.34%
EVGNEvogene Ltd-0.17-1.97%
PAHPlatform Specialty P...-0.33-1.81%
Data as of 4:03pm ET, 09/04/2015

Financials

Last reporting dateAugust 6, 2015
EPS forecast (this quarter)-$1.19
Annual revenue (last year)$0.00
Annual profit (last year)-$135.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Keith R. Leonard
Vice President-
Operations
Douglas A. Rich
Corporate headquarters
Westlake, California

Forecasts

Partner Offers